Alzheimer's in Long-Term Care--Treatment for Agitation

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Alzheimer DiseasePsychomotor Agitation
Interventions
DRUG

prazosin

"Participants taking prazosin. Prazosin was administered as 1 or 2 mg capsules. Doses were initiated at 1 mg at bedtime. Titration based on tolerability was conducted up to a dose of 2 mg in the morning plus 4mg at bedtime.~Duration was 8 weeks."

DRUG

placebo (inert substance)

Placebo is an inert substance used as a standard comparator in clinical pharmacologic trials. Duration is 8 weeks.

Trial Locations (1)

98108

Veterans Affairs Puget Sound Health Care System, Seattle

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Washington

OTHER

NCT00161473 - Alzheimer's in Long-Term Care--Treatment for Agitation | Biotech Hunter | Biotech Hunter